Table 2.
Study Participation | Baseline | 1 Month | 6 Months | 12 Months |
---|---|---|---|---|
Participated | 419 | 338 (80.7) | 316 (75.4) | 284 (67.8) |
Deceased (total) | NA | 12 (2.9) | 24 (5.7) | 34 (8.1) |
Too ill | NA | 19 (4.5) | 8 (1.9) | 13 (3.1) |
Missing | NA | 50 (11.9) | 71 (17.0) | 88 (21.0) |
Outcome measure missing | 9 (2.1) | 3 (0.7) | 14 (3.3) | 12 (2.9) |
Total sample by follow-up interview* | 410 (97.9) | 366 (87.4) | 334 (79.7) | 319 (76.1) |
NOTE. Values are n (%).
Abbreviation: NA, not applicable.
The sample included in the analysis of each assessment interval was dependent on the availability of a complete outcome score for the relevant time points or documentation of illness or having died in order to be categorized into the decline group.
(Sample total calculated for each follow-up assessment as the number who participated + the deceased + participants who were too ill – the number missing a measured outcome.)